CINXE.COM
How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology
<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <title> How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology </title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="canonical" href="https://www.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/" /> <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-YK7FCK71TD"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-YK7FCK71TD'); </script> <meta name="description" content="" /> <meta name="keywords" content="" /> <!-- Twitter Card data --> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:title" content="How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology"> <meta name="twitter:description" content=""> <meta name="twitter:image" content="https://www.biopharmatrend.com/files/blog/social/bpt_interviews_laurence_barker_soc.jpg"> <!-- Open Graph data --> <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/" /> <meta property="og:title" content="How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology" /> <meta property="og:description" content="" /> <meta property="article:published_time" content="2024-02-23T18:06:08+00:00"> <meta property="article:modified_time" content="2024-02-23T18:06:08+00:00"> <meta name="author" content="Andrii Buvailo, PhD"> <meta property="og:image" content="https://www.biopharmatrend.com/files/blog/social/bpt_interviews_laurence_barker_soc.jpg"> <script type="application/ld+json">{ "@context": "https://schema.org", "@type": "Article", "headline": "How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology", "datePublished": "2024-02-23T18:06:08+00:00", "dateModified": "2024-02-23T18:06:08+00:00", "description": "In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia Discovery Fund franchise, we discussed the evolving landscape of biotechnology and the strides toward tackling dementia and other neurodegenerative conditions.", "image": "https://www.biopharmatrend.com/files/blog/social/bpt_interviews_laurence_barker_soc.jpg", "url": "https://www.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/" }, "publisher": { "@type": "Organization", "name": "BiopharmaTrend", "url": "https://www.biopharmatrend.com", "logo": { "@type": "ImageObject", "url": "https://www.biopharmatrend.com/static/img/bpt_logo.png" } }, "author": [ { "@type": "Person", "name": "Andrii Buvailo, PhD", "url": "https://www.biopharmatrend.com/contributor/9/" } ] }</script> <style type="text/css"> .ap-chart-load svg { width: 100%; } .post-meta .author-linkein-icon { width: 1em; vertical-align: baseline; } .text-miniblock { display: inline-block; box-shadow: 0 0 6px -1px forestgreen; background: white; padding: 0.5rem; } .post .text-miniblock a { color: black; } .post .text-miniblock a:hover, .post .text-miniblock a:active { color: #333; text-decoration: underline; } .text-miniblock-right { float: right; margin: 0 0 1rem 1rem; max-width: 14rem; } .subscribe-block { background-color: deepskyblue; color: white; margin-top: 1.5rem; margin-bottom: 2rem; padding-top: 1.5rem; padding-bottom: 1.5rem; width: calc(50% + 100vw); padding-left: calc(50vw - 50%); padding-right: 50vw; margin-left: calc(50% - 50vw); position: relative; } .subscribe-block > .subscribe-inner { background-image: url('/files/subscription-bg.png'); background-position: right bottom; background-size: auto 120%; background-repeat: no-repeat; } .mobile-only { display: none; } @media screen and (max-width: 34em) { .text-miniblock-right { float: none; margin: 1rem 0; max-width: 100%; } .subscribe-block > .subscribe-inner { background-image: unset; } .mobile-only { display: block; } } </style> <link rel="shortcut icon" href="/static/favicon.ab1145f4d518.ico" /> <link rel="stylesheet" type="text/css" href="/static/css/main.6dead4e2266d.css" /> </head> <body> <div id="main-preheader"> <div class="container block-preheader"> <div id="logo-top"> <a href="/"><b>BioPharmaTrend</b></a> <!-- <a href="/"><img src="/files/bpt_logo2.svg" alt="BioPharmaTrend" style="max-height: 1em;" /></a> --> </div> <div class="burger-container"> <div class="burger-button-container"> <button type="button" class="burger-button" onclick="document.documentElement.classList.toggle('blockfix');this.parentElement.parentElement.classList.toggle('active');"> <div class="burger-line burger-line-1"></div> <div class="burger-line burger-line-2"></div> <div class="burger-line burger-line-3"></div> </button> </div> <!-- Search block --> <div id="main-search-menu"> <div class="top-search"> <form action="/search/" class="top-search-form"> <button type="submit" class="btn btn-default"><i class="glyphicon glyphicon-search"></i></button> <input type="text" name="q" value="" size="10" class="form-control form-control-inline" required="" placeholder="e.g. 'quantum tech' or 'stem cell'"> <input type="hidden" name="section" value="insights"> </form> <span class="top-search-switcher button" onclick="this.parentElement.classList.toggle('active')"> <span class="glyphicon glyphicon-search"></span> <span class="glyphicon glyphicon-remove"></span> </span> </div> <span class="top-search-switcher button"> <span class="glyphicon glyphicon-search"></span> </span> </div> <!-- Main Menu block --> <nav id="main-menu"> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/news/"><b>Latest News</b></a> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">All Topics <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/topic/bioeconomy-society/">Bioeconomy & Society</a></li> <li><a class="top-menu-link" href="/topic/ai-digital/">AI & Digital</a></li> <li><a class="top-menu-link" href="/topic/startups/">Startups & Deals</a></li> <li><a class="top-menu-link" href="/topic/neurotech/">NeuroTech</a></li> <li><a class="top-menu-link" href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a class="top-menu-link" href="/topic/synbio/">Biotech</a></li> <li><a class="top-menu-link" href="/topic/tools-methods/">Tools & Methods</a></li> <li><a class="top-menu-link" href="/topic/healthtech/">HealthTech</a></li> <li><a class="top-menu-link" href="/topic/aging-research/">Aging & Longevity</a></li> <li><a class="top-menu-link" href="/topic/contract-research/">Contract Research</a></li> <div class="sub-menu-margin"></div> <!--<li><a class="top-menu-link" href="/ai-drug-discovery-pipeline/">Historical Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/section/latest/">Latest insights</a></li> <li><a class="top-menu-link" href="/premium-content/">Premium Content</a></li> <div class="sub-menu-margin" style="border-bottom: 1px solid limegreen;"></div> <li><a class="top-menu-link" href="/knowledge-center/">Knowledge Center</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/interviews/"><b>Interviews</b></a> </div> <!-- <div class="mobile-menu-item"> <b class="mobile-menu-item-title">Library</b> </div> --> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">Companies <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <!-- <li><a class="top-menu-link" href="/post/789-a-landscape-of-ai-discovered-molecules-and-target-novelty-analysis/">AI Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/m/marketplace/">Company Directory</a></li> <li><a class="top-menu-link" href="/section/interviews/">Interviews with Thought Leaders</a></li> <li><a class="top-menu-link" href="/section/case-studies/">Sponsored Case Studies</a></li> <li><a class="top-menu-link" href="/m/editor-tool/">Create Company Profile</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">More <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/about/">About Us</a></li> <li><a class="top-menu-link" href="/about/team/">Our Team</a></li> <li><a class="top-menu-link" href="/about/advisory-board/">Advisory Board</a></li> <li><a class="top-menu-link" href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a class="top-menu-link" href="/events/">Partner Events Calendar</a></li> <li><a class="top-menu-link" href="/advertising-media-kit/">Advertise with Us</a></li> <li><a class="top-menu-link" href="/contributor/">Write for Us</a></li> </ul> </div> </div> </nav> </div> <div id="main-user-actions"> <!-- Subscribe block --> <div class="mobile-menu-item"> <a href="/membership/" class="button-subscribe top-menu-link">Subscribe</a> </div> <!-- User menu --> <div class="mobile-menu-item last"> <a href="#" class="mobile-menu-item-title" rel="nofollow" title="Login/Join" onclick="document.getElementById('login-popup').classList.toggle('hidden')"> <span class="glyphicon glyphicon-log-in"></span> <span class="mobile-hide-m">Login/Join</span> </a> </div> </div> </div> </div> <div id="main-preheader-margin"></div> <div id="sencondary-menu-block"> <div class="container clearfix"> <nav> <ul class="text-center"> <li><a href="/topic/ai-digital/">AI & Digital</a></li> <li><a href="/topic/startups/">Startups & Deals</a></li> <li><a href="/topic/neurotech/">NeuroTech</a></li> <li><a href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a href="/topic/synbio/">Biotech</a></li> <li><a href="/topic/tools-methods/">Tools & Methods</a></li> </ul> </nav> </div> </div> <!-- <header id="main-header" class="brand-block"> <div class="container clearfix"> </div> </header> --> <div id="main-content" class="container"> <main id="content" class="col-lg-9 col-md-8 col-sm-12 col-xs-12"> <div class="mobile-only"> </div> <article id="post-763" class="post "> <header> <h1>How Precision Neuroscience and Drug Synergies Could Revolutionize Neurology</h1> </header> <footer class="post-meta"> <div class="tooltip"> <span class="glyphicon glyphicon-pencil"></span> by <a href="/contributor/9/">Andrii Buvailo, PhD</a> <a href="https://www.linkedin.com/in/andriibuvailo/" rel="nofollow" target="_blank"> <img src="/static/img/linkedin_icon_50x50.71dcf83d1029.png" class="author-linkein-icon" /> </a> </span> <span style="white-space: nowrap;"> <span class="glyphicon glyphicon-folder-open"></span> Interview </span> <div class="tooltip-text"> <div class="tooltip-close" onclick="this.parentElement.parentElement.classList.toggle('tooltip-show');"></div> <p><b>Disclaimer</b>: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. <br> Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.</p> </div> </div> <div> <span class="glyphicon glyphicon-calendar" title="Published on"></span> <time datetime="2024-02-23">Feb. 23, 2024</time> </em> </div> <div class="tags"> <b>Topics: </b> <a href="/topic/neurotech/">NeuroTech</a> </div> <div> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> | <a href="/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/pdf/" target="_blank" rel="nofollow"> <span style="vertical-align: text-top; color: deepskyblue; font-size: 1.5em;" class="glyphicon glyphicon-print"></span></a> </div> </footer> <section> <p>In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia Discovery Fund franchise, we discussed the evolving landscape of biotechnology and the strides toward tackling dementia and other neurodegenerative conditions.</p> <p style="text-align: center;"><a href="https://www.techlifesci.com/p/how-precision-neuroscience-and-drug" target="_blank"><img alt="" src="/files/uploads/2024/04/16/bpt_interviews_laurence_barker.webp" /></a></p> <p style="text-align: center;"><a href="https://www.techlifesci.com/p/how-precision-neuroscience-and-drug" target="_blank">View the interview videocast with Laurence in our newsletter</a></p> <p> </p> <p>Laurence's insights shed light on the critical role of so-called “precision neuroscience” in addressing one of today's most daunting medical challenges: dementia. </p> <p>Drug discovery related to neurodegenerative diseases is, characterized by a high rate of clinical trial failures and a dire need for effective therapeutics, stands as a significant hurdle in medical science. </p> <p>Laurence's commitment through the Dementia Discovery Fund underscores the urgency and potential within this space. By investing in and building companies focused on novel mechanisms, the fund aims to leverage global science in pursuit of breakthrough treatments.</p> <p>For instance, the DDF's dedication to propelling the field of precision neuroscience into new heights is exemplified by their support for companies like Alchemab Therapeutics and Cerevance, both at the forefront of leveraging artificial intelligence (AI) and big data in the battle against neurodegenerative diseases.</p> <p><a href="https://www.alchemab.com/">Alchemab Therapeutics</a> stands out for its innovative approach to identifying protective antibodies in individuals who have remained free from neurodegenerative conditions. By employing AI to sift through extensive antibody repertoires, Alchemab seeks out unique subsets that offer a shield against diseases such as Alzheimer's. This pursuit not only highlights the DDF's commitment to exploring the body's innate disease-fighting mechanisms but also underscores the pivotal role of data analysis in pioneering new avenues for treatment.</p> <blockquote> <p>RELATED: <a href="https://www.biopharmatrend.com/post/744-neuroscience-diagnostics-and-therapeutics-are-a-600-billion-market/">Neuroscience is a $600+ Billion Market</a></p> </blockquote> <p>On the other hand, <a href="https://www.cerevance.com/">Cerevance</a>, with its roots in Cambridge, is making strides with its platform technology focused on the neuroinflammatory pathways implicated in Alzheimer's disease. The company's ability to draw in significant partnerships, notably with pharmaceutical giant Merck, speaks volumes about the UK's capacity to nurture collaborative ecosystems conducive to innovation. These alliances, fueled by DDF's investment, are critical in speeding up the journey from groundbreaking research to life-altering treatments.</p> <p>The backing of Alchemab Therapeutics and Cerevance by the DDF is reflective of a broader strategy aimed not merely at funding existing ventures but at stimulating the biotech landscape to cultivate and support new entities from inception.</p> <p> </p> <h2>The Role of Precision Neuroscience</h2> <p>At the heart of Laurence's discussion is the concept of precision neuroscience—a term that encapsulates the future of neurodegenerative disease treatment. </p> <p>Drawing parallels with the success of precision medicine in oncology, Barker emphasizes the necessity of understanding individual patient profiles and disease states. This approach is pivotal in developing effective drug combinations, marking a paradigm shift from single-agent therapies to more nuanced, synergistic treatment strategies.</p> <p>Artificial intelligence (AI) and data play indispensable roles in this new era of precision neuroscience. </p> <p>With the UK pioneering significant genomics initiatives, such as the UK Biobank and the Future Health project, vast datasets are becoming available. These resources are invaluable for understanding disease progression, identifying biomarkers, and tailoring treatments to individual patient profiles. </p> <p>Laurence highlights several examples within the Dementia Discovery Fund's portfolio where AI-driven analysis of genetic, proteomic, and clinical data is leading to groundbreaking target discovery and therapeutic development.</p> <p>Notably, Laurence emphasized the significant potential of drug combination strategies in the treatment of neurodegenerative diseases, particularly dementia. </p> <p>According to his ideas, future breakthroughs in this field are likely to emerge from understanding how drugs can be used together in synergistic or complementary ways to maximize their therapeutic impact. </p> <p>Drawing on successful precedents in oncology, where combination therapies have revolutionized treatment, Laurence suggests a similar approach could yield substantial benefits in neurodegeneration.</p> <blockquote> <p>RELATED: <a href="https://www.biopharmatrend.com/post/704-ai-breaches-the-barrier-towards-better-cns-drug-discovery/">AI Breaches the Barrier Towards Better CNS Drug Discovery</a></p> </blockquote> <p>This shift toward combination therapies, informed by precision neuroscience, represents a hopeful horizon for tackling diseases that have long been considered intractable.</p> <p> </p> <h2>The UK's Biotech Ecosystem and Global Leadership</h2> <p>The interview also touches on the UK's vibrant biotech ecosystem, which Barker believes is well-positioned to lead in the biotech revolution, provided it continues to foster innovation, attract global talent, and secure investment. </p> <p>Key to maintaining and expanding this leadership will be enhancing the venture capital landscape, supporting a conducive regulatory environment, and facilitating clinical research within the NHS framework.</p> <p>Looking ahead, Barker is optimistic about the potential of precision neuroscience to transform the treatment landscape for dementia and other neurodegenerative diseases. By embracing a combination therapy approach, informed by robust data and AI technologies, the field stands on the cusp of advancement.</p> <div class="product-list"> </div> <p> <b>Topics: </b> <a href="/topic/neurotech/">NeuroTech</a> </p> </section> </article> <div style="margin: 1em 0 2em; padding: 0.5em 0;"> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> </div> <div class="subscribe-block"> <div class="subscribe-inner"> <h3 style="line-height:1.5; font-weight: 900;"> <span style="font-weight: 900">Get Exclusive Insights Into Your Inbox</span> <br> <span style="font-weight: normal;">join 7000+ BPT insiders</span> </h3> <br> <div> <a style="font-size: 1.25em;width:17em; text-align: center; border-color: white; color: white; font-weight: 900" href="#" onclick="toggleMailingPopup(true)" class="btn">Subscribe</a> </div> </div> </div> <section id="comments"> </section> </main> <aside id="main-sidebar" class="col-lg-3 col-md-4 col-sm-12 col-xs-12"> <section class="well"> <h4>Latest Articles</h4> <ul> <li><a href="/post/970-this-company-sets-a-new-milestone-with-worlds-first-human-graphene-brain-computer-interface/">This Company Sets a New Milestone with World鈥檚 First Human Graphene Brain-Computer Interface</a></li> <li><a href="/post/936-eth-zurichs-flexible-brain-probes-a-safer-twist-in-the-bci-journey/">ETH Zurich鈥檚 Flexible Brain Probes: A Safer Twist in the BCI Journey</a></li> <li><a href="/post/922-piramidals-ai-transforming-neurological-diagnostics-by-decoding-brainwaves/">Piramidal's AI: Transforming Neurological Diagnostics by Decoding Brainwaves</a></li> <li><a href="/post/913-blackrock-neurotech-restores-als-patients-speech-using-brain-computer-interface/">Blackrock Neurotech Restores ALS Patient's Speech Using Brain-Computer Interface</a></li> <li><a href="/post/881-companies-making-waves-in-neurotech-space/">12 Emerging Companies to Watch in Neurotech Space</a></li> <li><a href="/post/857-synchron-integrates-generative-ai-with-brain-computer-interface-software/">Synchron Integrates Generative AI with Brain-Computer Interface Software</a></li> </ul> </section> </aside> </div> <footer id="main-footer"><div class="container"> <div class="row"> <div class="col-12 col-sm-6 col-lg-3"> <h4 class="footer-logo"><span style="font-weight: 900">BiopharmaTrend</span>.com</h4> <div style="margin-bottom: 1.25em" class="footer-logo-slogan">Where Tech Meets Bio</div> <!-- <p> <a style="color: #fff;border-color: #fff;" href="#main-footer" onclick="toggleMailingPopup(true)" class="btn"><b>Newsletter</b></a> </p> <p> <a href="https://www.linkedin.com/company/18118496" rel="nofollow" target="_blank"><img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /></a> <a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"><img src="/static/img/sm-tw.f721ec7f127d.png" alt="tw" width="32" height="32" /></a> <a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"><img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /></a> <a href="/rss/" rel="nofollow" target="_blank"><img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /></a> </p> --> <div style="margin-bottom: 0.5em;"><a href="#main-footer" onclick="toggleMailingPopup(true)" style="color: lemonchiffon"> <img src="/static/img/sm-mail.a3210e82fe37.png" alt="mail" width="32" height="32" /> <b>Newsletter</b> </a></div> <div style="margin-bottom: 0.5em"><a href="https://www.linkedin.com/company/biopharmatrend-com/" rel="nofollow" target="_blank"> <img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /> LinkedIn </a></div> <div style="margin-bottom: 0.5em"><a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"> <img src="/static/img/sm-x.9f3327271e1a.png" alt="x" width="32" height="32" /> X </a></div> <div style="margin-bottom: 0.5em"><a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"> <img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /> Google News </a></div> <div><a href="/rss/" rel="nofollow" target="_blank"> <img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /> RSS Feed </a></div> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>About</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/about/">What we do</a></li> <li><a href="/editorial-calendar/">Editorial Calendar</a></li> <li><a href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a href="/terms-of-use/">Terms of Use</a></li> <li><a href="/privacy-policy/">Privacy Policy</a></li> <!--<li><a href="/cookies-policy/">Cookies Policy</a></li>--> <li><a href="/about/disclaimer/">Disclaimer</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>We Offer</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/premium-content/"><b style="color: lemonchiffon">Premium Content</b></a></li> <li><a href="/m/marketplace/">BioTech Scout</a></li> <li><a href="/our-products/">Reports</a></li> <li><a href="/section/interviews/">Interviews</a></li> <li><a href="/events/">Partner Events</a></li> <li><a href="/section/case-studies/">Case Studies</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>Opportunities</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/membership/">Membership</a></li> <li><a href="/advertising-media-kit/">Advertise</a></li> <li><a href="/m/editor-tool/">Submit Company</a></li> <li><a href="/contributor/">Write for Us</a></li> <li><a href="/guest-blog/guidelines/">Author Guidelines</a></li> <li><a href="/a/contact/">Contact Us</a></li> </ul> </nav> </div> </div> <hr> <div class="text-right">© BPT Analytics LTD 2024</div> </div></footer> <div id="bpt-consent"><div class="container"> <div class="row"> <div class="col-12 col-md-6 col-lg-8"> We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our <a href="/cookies-policy/">cookies policy</a>. </div> <div class="col-12 col-md-6 col-lg-4 text-right"> <button class="btn btn-primary btn-sm" type="button" onclick="changeConsent('analytics')" style="white-space:unset">Agree</button> </div> </div> </div></div> <div id="login-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div class="popup-content" style="width: 25em;"> <form method="post" class="api-form" action="/a/login/?next=/post/763-how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/"></form> </div> </div> <div id="subscription-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div id="subscription-popup-iframe" class="popup-content" style="width: 25em;"> </div> </div> <div id="scroll-top-pixel-anchor"></div> <button id="go-top" onclick="window.scrollTo({top: 20, left: 0, behavior: 'smooth'})">^</button> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script> <script src="/static/js/main.df923d2272d3.js"></script> <script type="text/javascript"> if ( "IntersectionObserver" in window && "IntersectionObserverEntry" in window && "intersectionRatio" in window.IntersectionObserverEntry.prototype ) { let observer = new IntersectionObserver(entries => { if (entries[0].boundingClientRect.y < 0) { document.body.classList.add("scroll-top"); } else { document.body.classList.remove("scroll-top"); } }); observer.observe(document.getElementById("scroll-top-pixel-anchor")); } </script> <script src="/static/js/blog-ajax.eb8cbd906073.js"></script> <script> const comments_url = "/blog-api/comments/post-763"; post_comments_load(); </script> </body> </html>